Ramsay, RR, Popovic-Nikolic, MR, Nikolic, K., Uliassi, E. & Bolognesi, ML Perspectives on multi-target drug discovery and design for complex diseases. Clin. translation. medicine. 73 (2018).
Google Scholar
Halli-Tierney, AD, Scarbrough, C. & Carroll, D. Polypharmacy: Assessing risk and deprescribing. morning. Fam. doctor 10032–38 (2019).
Google Scholar
Makhaba, XH, Viegas Jr, C., Mosa, RA, Viegas, FP & Pooe, OJ Potential impact of multitargeted drug approaches in the treatment of several complex diseases. Research and develop drugs. So. 143235–3249 (2020).
Katsoulaki, E.-E., Dimopoulos, D. & Hadjipavlou-Litina, D. Multitargeted compounds designed for Alzheimer’s disease, Parkinson’s disease, and Huntington’s neurodegenerative disease. pharmaceuticals 18831 (2025).
Google Scholar
Doostmohammadi, A., Jooya, H., Ghorbanian, K., Gohari, S., Dadashpour, M. Potential and future prospects of multitargeted drugs in cancer treatment: Next generation anticancer drugs. cell commune. signal. twenty two228 (2024).
Google Scholar
Zhang, K. et al. Artificial intelligence in drug development. nut. medicine. 3145–59 (2025).
Google Scholar
Tanoli, Z. et al. Computational drug repurposing: approaches, in silico resource evaluation, and case studies. nut. Rev.DrugDiscov. twenty four521–542 (2025).
Savander, S. et al. Data-driven strategies for drug repurposing: Insights, recommendations, and case studies. Easy. Bioinformatics. 26bbaf625 (2025).
Google Scholar
Reinshagen, J. et al. From library to landscape: an integrated annotation workflow for compound libraries in drug repurposing. database 2025baaf081 (2025).
Google Scholar
Ianevski, A. et al. RePurposedrugs: an interactive web portal and predictive platform for repurposing monotherapies and combination therapies. Easy. Bioinformatics. twenty fivebbae328 (2024).
Google Scholar
Aldahdooh, J., Tanoli, Z., and Tang, J. Mining drug-target interactions from the biomedical literature using ensemble transformer models based on chemical and genetic descriptions. Bioinformatics. advanced 4vbae106 (2024).
Google Scholar
Aldahdooh, J., Vähä-Koskela, M., Tang, J., Tanoli, Z. Identifying drug-target interactions across PubMed using bert. BMC bioinformatics. twenty three245 (2022).
Google Scholar
Legehar, A. et al. Ecodrug plus: an advanced database for conservation analysis and environmental risk assessment of pharmaceutical targets. Nucleic acid research institute 54D1397–D1404 (2026).
Google Scholar
Tang, X. et al. Exploring generative AI for novel drug design: new frontiers in molecular and protein production. Easy. bioinf. twenty fivebbae338 (2024).
Kang, SI, Shin, JH, Wu, BM & Choi, HS Deep generative AI for multi-target therapy design: Towards a self-improving drug discovery framework. internal. J. Mol. Science. 2611443 (2025).
Google Scholar
Zou, Y. et al. A structure-based framework for selective inhibitor design and optimization. common. Biol. 8422 (2025).
Google Scholar
Stiller, T., Duensing-Kropp, S., Marschner, JA & Merk, D. Fragment-based discovery of dual-ligand pharmacophores of lipid-sensing transcription factors for engineered polypharmacology. RSC Medicine. Chemistry. 165012–5024 (2025).
Google Scholar
Isigkeit, L. et al. Automatic design of multitarget ligands by generative deep learning. nut. common. 157946 (2024).
Google Scholar
Liu, X. et al. Drugex v2: Novel design of drug molecules using Pareto-based multi-objective reinforcement learning in polypharmacology. J. Cheminf. 1385 (2021).
Google Scholar
Li, Y., Lin, X., Hao, Y., Zhang, J. & Gao, YQ Molsculptor: A diffusion evolution framework for multisite inhibitor design. ChemRxiv (2025).
Ertl, P. & Schuffenhauer, A. Estimating the synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminf. 18 (2009).
Google Scholar
Bickerton, GR, Paolini, GV, Besnard, J., Muresan, S., Hopkins, AL Quantifying the chemical beauty of drugs. nut. Chemistry. 490–98 (2012).
Google Scholar
Swanson, K. and others. Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. nut. Mach. intelligence. 6338–353 (2024).
Google Scholar
Koziarski, M. et al. Rgfn: Synthesizable molecule generation using gflownet. Advanced neural information processes. system. 3746908–46955 (2024).
Google Scholar
Coley, CW, Barzilay, R., Jaakkola, TS, Green, WH & Jensen, KF Predicting organic reaction outcomes using machine learning. ACS St. Science. 3434–443 (2017).
Google Scholar
Genheden, S. et al. Aizynthfinder: Fast, robust, and flexible open-source software for retrosynthesis planning. J. Cheminf. 1270 (2020).
Google Scholar
Fromer, JC & Coley, CW An algorithmic framework for synthetic cost-aware decision making in molecular design. nut. Calculate. Science. 4440–450 (2024).
Google Scholar
Kim, H. et al. Targeting jnk3 against Alzheimer’s disease: Design and synthesis of novel inhibitors with wide pocket aryl group diversity. EUR. J.Med.Chemistry. 285117209 (2025).
Google Scholar
Wang, D. et al. Combined inhibition of pi3k and parp is effective in treating ovarian cancer cells with wild-type PIK3CA gene. Guinecole. Oncor. 142548–556 (2016).
Google Scholar
Schertens, P. et al. Alzheimer’s disease. lancet 3971577–1590 (2021).
Google Scholar
Gong, C.-X., Liu, F. & Iqbal, K. Multifactorial hypothesis and multiple targets of Alzheimer’s disease. J. Alzheimer’s disease. Dis. 64S107–S117 (2018).
Google Scholar
Probst, GD et al. Highly selective c-jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration. Bioorg. medicine. Chemistry. Let. twenty one315–319 (2011).
Google Scholar
Buonfiglio, R. et al. Discovery of a novel imidazopyridine gsk-3β Inhibitors supported by computational approaches. molecule twenty five2163 (2020).
Google Scholar
Shuai, W. et al. Discovery of a novel indazole chemotype as an isoform-selective JNK3 inhibitor for the treatment of Parkinson’s disease. J.Med.Chemistry. 661273–1300 (2023).
Google Scholar
Jason, GC, Cohn, EC, Kitchener, HC, Lederman, JA Ovarian cancer. lancet 3841376–1388 (2014).
Google Scholar
Murawski, M., Jagodziński, A., Bielawska-Pohl, A. & Klimczak, A. Complexity of the genetic background of carcinogenesis in ovarian cancer – genetic instability and clinical impact. cell 13345 (2024).
Google Scholar
Walker, E.H. et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, ly294002, quercetin, myricetin, and staurosporine. Mol. cell 6909–919 (2000).
Google Scholar
Ogden, TE et al. Dynamics of the hd regulatory subdomain of parp-1. Substrate access and allostery in parp activation and inhibition. Nucleic acid research institute 492266–2288 (2021).
Google Scholar
Oord, A. vd, Li, Y., Vinyals, O. Representation learning with contrastive predictive coding. arXiv preprint arXiv:1807.03748 (2018).
Castro, E. et al. Transformer-based protein generation with normalized latent space optimization. nut. Mach. intelligence. 4840–851 (2022).
Google Scholar
Schulman, A., Rousu, J., Aittokallio, T., Tanoli, Z. An attention-based approach to predicting drug-target interactions across seven target superfamilies. bioinformatics 40btae496 (2024).
Google Scholar
McNutt, AT et al. Sprint enables interpretable, ultra-fast virtual screening of thousands of proteomes. arXiv electronic print arXiv–2411 (2024).
Passaro, S. et al. Voltz-2: Towards accurate and efficient binding affinity prediction. BioRxiv 2025-2006 (2025).
Chen, T., Kornblith, S., Norouzi, M. & Hinton, G. A simple framework for contrastive learning of visual representations. in International Conference on Procedural Machine Learning1597–1607 (PMLR, 2020).
Huang, Y. et al. Dsdp: GPU-accelerated blind docking strategy. J. Chem. information model. 634355–4363 (2023).
Google Scholar
RDKit — rdkit.org. https://www.rdkit.org/.
Deb, K., Pratap, A., Agarwal, S. & Meyarivan, T. A fast and elitist multi-objective genetic algorithm: Nsga-ii. IEEE Trans. Evolute. Calculate. 6182–197 (2002).
Google Scholar
Chemspace Services: Compound sourcing and sourcing, hit discovery, molecular docking, custom synt — chem-space.com. https://chem-space.com/services.
